search
Back to results

Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention (PEACE)

Primary Purpose

Anxiety

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PEACE Program
Sponsored by
Duke University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Anxiety

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)FemaleAccepts Healthy Volunteers

Inclusion Criteria:

  • female sex
  • diagnosis of non-metastatic stage I-III cervical or endometrial cancer
  • 18 years of age or older
  • able to speak/read English
  • able to give informed consent
  • completed cancer treatments within 2-24 months prior to enrollment, and recommended to undergo surveillance pelvic examination at three month intervals
  • able to commit to three 45-60 minute visits within the study period
  • able to participate in the intervention via the telemedicine modality (e.g., phone or video)

Exclusion Criteria:

  • unable to provide informed consent
  • major untreated or uncontrolled mental illness
  • hearing impairment that impedes telephone or video calls

Sites / Locations

  • Duke University Medical Center

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

PEACE Program

Arm Description

3 sessions of tailored coping skills related to pelvic examinations

Outcomes

Primary Outcome Measures

Intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)
The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).
Change in intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)
Change in intervention acceptability from immediately after completion of the 3 sessions (post intervention assessment) to after trying to implement the coping skills during their next pelvic examination (post pelvic exam assessment), using the STTS-R. The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).
Intervention feasibility as measured by percentage of recruited participants who enrolled
Enrollment logs will capture the number of participants who were recruited and among them, the number that enrolled in the study.
Intervention feasibility as measured by attrition
Retention logs will capture the number of participants who did not complete the study protocol (rate of attrition)
Intervention feasibility as measured by survey completion
Retention logs will capture the number of participants who completed all assessments
Intervention feasibility as measured by home practice completion
Interventionist logs completed at the conclusion of each session will capture the level of home practice completion
Intervention feasibility as measured by participant engagement
Interventionist logs completed at the conclusion of each session will capture the level of participant engagement with a 1 item question rated from 1 (not at all engaged) to 4 (highly engaged).
Intervention feasibility as measured by interventionist fidelity
Fidelity rating forms will be used to measure the level of fidelity to session content for one third of the sessions for the protocol. Each component of the session will be rated from 0 (not covered at all) to 3 (thoroughly covered the topic)

Secondary Outcome Measures

Change in anxiety related to examination as measured by the The State Anxiety Scale of the State-Trait Anxiety Inventory
The State Anxiety Scale of the STAI is comprised of 20 items on a 5-point Likert scale, which range from 1 (not at all) through 4 (very much).
Change in pain during examination as measured by numeric scales
Numeric scales will be used to assess the average pain during examination, worst pain during examination, and lowest pain during examination, ranging from 0 (no pain) to 10 (pain as bad as you could imagine). The three pain intensity ratings will be averaged to create a total score for pain.

Full Information

First Posted
March 7, 2022
Last Updated
May 10, 2023
Sponsor
Duke University
search

1. Study Identification

Unique Protocol Identification Number
NCT05285306
Brief Title
Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention
Acronym
PEACE
Official Title
Developing and Pilot Testing a Brief Intervention to Reduce Anxiety During Pelvic Examinations Among Female Cancer Survivors (Pelvic Examination and Anxiety Coping Skills for Empowerment: PEACE)
Study Type
Interventional

2. Study Status

Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
March 21, 2022 (Actual)
Primary Completion Date
September 2, 2022 (Actual)
Study Completion Date
September 2, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Duke University

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The purpose of this study is to test the feasibility and acceptability of a brief coping skills training program addressing anxiety and pain related to surveillance pelvic examinations for female gynecologic cancer survivors.
Detailed Description
The investigators have developed and manualized a coping skills training intervention for female gynecologic cancer patients that aims to reduce anxiety related to surveillance pelvic examinations (Pelvic Examination and Anxiety Coping Skills for Empowerment: PEACE). The investigators propose a proof-of concept pilot study to evaluate the acceptability and feasibility of the coping skills intervention. The study will be conducted by Duke University. Participants (N=16) will receive the 3-session telemedicine coping skills intervention. Participants will complete assessments at baseline, post-intervention (within 2 weeks before their next scheduled pelvic examination), and post pelvic examination (2-3 months after the baseline assessment). Study aims are: Aim 1) Assess intervention acceptability and feasibility through quantitative measurement and qualitative feedback from semi-structured interviews, and Aim 2) Graphically depict patterns of change in outcome variables and intervention targets.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Anxiety

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
16 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PEACE Program
Arm Type
Experimental
Arm Description
3 sessions of tailored coping skills related to pelvic examinations
Intervention Type
Behavioral
Intervention Name(s)
PEACE Program
Other Intervention Name(s)
Pelvic Exam and Anxiety Coping Skills for Empowerment
Intervention Description
This pilot will consist of 3 individual telemedicine sessions to teach cognitive behavioral coping skills and provide education related to gynecologic cancer surveillance and psychological distress.
Primary Outcome Measure Information:
Title
Intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)
Description
The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).
Time Frame
post pelvic examination (approximately 2-3 months after baseline)
Title
Change in intervention acceptability will be assessed using an adapted version of the Satisfaction with Therapy and Therapist Scale (STTS-R)
Description
Change in intervention acceptability from immediately after completion of the 3 sessions (post intervention assessment) to after trying to implement the coping skills during their next pelvic examination (post pelvic exam assessment), using the STTS-R. The adapted STTS-R consists of 18 items that assess satisfaction with the therapist and the intervention on a 5-point Likert-type scale from 1 (strongly disagree) to 5 (strongly agree).
Time Frame
post-intervention (within 2 weeks of their next pelvic examination), post pelvic examination (approximately 2-3 months after baseline)
Title
Intervention feasibility as measured by percentage of recruited participants who enrolled
Description
Enrollment logs will capture the number of participants who were recruited and among them, the number that enrolled in the study.
Time Frame
post pelvic examination (approximately 2-3 months after baseline)
Title
Intervention feasibility as measured by attrition
Description
Retention logs will capture the number of participants who did not complete the study protocol (rate of attrition)
Time Frame
post pelvic examination (approximately 2-3 months after baseline)
Title
Intervention feasibility as measured by survey completion
Description
Retention logs will capture the number of participants who completed all assessments
Time Frame
post pelvic examination (approximately 2-3 months after baseline)
Title
Intervention feasibility as measured by home practice completion
Description
Interventionist logs completed at the conclusion of each session will capture the level of home practice completion
Time Frame
post-intervention (within 2 weeks of their next pelvic examination)
Title
Intervention feasibility as measured by participant engagement
Description
Interventionist logs completed at the conclusion of each session will capture the level of participant engagement with a 1 item question rated from 1 (not at all engaged) to 4 (highly engaged).
Time Frame
post-intervention (within 2 weeks of their next pelvic examination)
Title
Intervention feasibility as measured by interventionist fidelity
Description
Fidelity rating forms will be used to measure the level of fidelity to session content for one third of the sessions for the protocol. Each component of the session will be rated from 0 (not covered at all) to 3 (thoroughly covered the topic)
Time Frame
post-intervention (within 2 weeks of their next pelvic examination)
Secondary Outcome Measure Information:
Title
Change in anxiety related to examination as measured by the The State Anxiety Scale of the State-Trait Anxiety Inventory
Description
The State Anxiety Scale of the STAI is comprised of 20 items on a 5-point Likert scale, which range from 1 (not at all) through 4 (very much).
Time Frame
baseline, post-intervention (within 2 weeks of their next pelvic examination), post pelvic examination (approximately 2-3 months after baseline)
Title
Change in pain during examination as measured by numeric scales
Description
Numeric scales will be used to assess the average pain during examination, worst pain during examination, and lowest pain during examination, ranging from 0 (no pain) to 10 (pain as bad as you could imagine). The three pain intensity ratings will be averaged to create a total score for pain.
Time Frame
baseline, post pelvic examination (approximately 2-3 months after baseline)

10. Eligibility

Sex
Female
Gender Based
Yes
Gender Eligibility Description
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: female sex diagnosis of stage I-IV cervical or endometrial cancer 18 years of age or older able to speak/read English able to give informed consent completed cancer treatments within 2-24 months prior to enrollment, and recommended to undergo surveillance pelvic examination at three month intervals able to commit to three 45-60 minute visits within the study period able to participate in the intervention via the telemedicine modality (e.g., phone or video) Exclusion Criteria: unable to provide informed consent major untreated or uncontrolled mental illness hearing impairment that impedes telephone or video calls
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Rebecca Shelby, PhD
Organizational Affiliation
Duke University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Duke University Medical Center
City
Durham
State/Province
North Carolina
ZIP/Postal Code
27705
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

Surveillance Pelvic Examination Anxiety: Brief Coping Skills Intervention

We'll reach out to this number within 24 hrs